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Background: The purpose of this study is to evaluate the clinical impact of using deformable registration in tumor
volume definition between separately acquired PET/CT and planning CT images.
Methods: Ten lung and 10 head and neck cancer patients were retrospectively selected. PET/CT images were
registered with planning CT scans using commercially available software. Radiation oncologists defined two sets of
gross tumor volumes based on either rigidly or deformably registered PET/CT images, and properties of these
volumes were then compared.
Results: The average displacement between rigid and deformable gross tumor volumes was 1.8 mm (0.7 mm) with
a standard deviation of 1.0 mm (0.6 mm) for the head and neck (lung) cancer subjects. The Dice similarity
coefficients ranged from 0.76-0.92 and 0.76-0.97 for the head and neck and lung subjects, respectively, indicating
conformity. All gross tumor volumes received at least 95% of the prescribed dose to 99% of their volume.
Differences in the mean radiation dose delivered to the gross tumor volumes were at most 2%. Differences in the
fraction of the tumor volumes receiving 100% of the radiation dose were at most 5%.
Conclusions: The study revealed limitations in the commercial software used to perform deformable registration.
Unless significant anatomical differences between PET/CT and planning CT images are present, deformable
registration was shown to be of marginal value when delineating gross tumor volumes.
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Advances in imaging have made a profound impact in the
diagnosis and management of cancer. Techniques such as
Positron Emission Tomography (PET) and Computed
Tomography (CT) are now widely used for staging and
tumor delineation for lung and head and neck cancers
[1-6]. In particular, accurately defining target volumes in
radiation treatment planning is crucial to ensure proper
coverage of the tumors and spare organs at risk.
While PET images provide details on the extent and
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reproduction in any medium, provided the ordefine the anatomical details of the tumor and surround-
ing healthy tissues. To better correlate the location of
the 18F-fluorodeoxyglucose (FDG) avid tumors from the
combined PET/CT images with the planning CT scan,
software can be deployed to co-register the images. Rigid
image registration (RIR) of the two CT images can ef-
fectively align the PET to the planning CT images to ac-
curately define the volumes for radiation treatment [7].
Many cancer centers have access to a diagnostic PET/
CT scanner, but not necessarily to a PET/CT radiation
therapy simulator [8]. Thus, PET/CT images are often
acquired at different time-points and locations in the ra-
diation treatment planning process, using various patienttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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PET/CT scanner is used for radiation treatment simula-
tion, the patient anatomy on the PET/CT does not al-
ways correspond to that of the planning CT. This can be
further complicated by changes in weight in the patient
between scans, changes in the positioning of the patient,
and soft tissue displacements due to breathing, peristal-
tic, cardiac or involuntary motion. Sophisticated registra-
tion methods have become available in the clinic to
account for these motions [9]. Deformable image regis-
tration (DIR) attempts to correct for these effects by
providing a mapping between volume elements in one
image to the corresponding volume elements in a sec-
ond image.
Although many studies investigating the performance
and utility of DIR have been conducted [10-16], no dosi-
metric information regarding the clinical impact of DIR
of PET/CT to planning CT has been found in the litera-
ture, nor any clinical studies validating the software
used. The purpose of this retrospective study is to assess
the utility and efficacy of DIR between PET/CT and
planning CT images for radiation therapy patients. The
impact of DIR on tumor volume definition is investi-
gated using radiation treatment plans for patients with
lung or head and neck cancer by quantitatively compar-
ing tumor volumes defined with RIR and DIR PET/CT
images using metrics such as the Dice similarity coeffi-
cient, displacement of the center of mass, and radiation
dose received.
Methods and materials
Research ethics was obtained from the University of
British Columbia research ethics board in conjunction
with the BC Cancer Agency. Twenty cancer patients be-
tween the age of 46 and 74 years were retrospectively se-
lected from the treatment-planning database: 10 lung
and 10 head and neck patients. All patients underwent
curative cancer treatment at the BC Cancer Agency in
Victoria between May 2012 and February 2013 using In-
tensity modulated radiotherapy (IMRT).
The CT simulation for head and neck patients was
performed at the treatment site with a GE Optima
CT580 scanner and patients were immobilized with a
thermoplastic shell. Patients were then sent to an im-
aging center with their shell, and imaged using a GE
Discovery 600/690 PET/CT scanner. Full body scans
were acquired with the patients immobilized in their
thermoplastic shell on a flat-top couch, and a high-
resolution PET/CT of the head and neck region was
generated for radiation treatment purposes. PET/CT
scans were performed 1-15 days after the acquisition of
the planning CT scans. Lung patients were immobilized
on a flat-top couch using an in-house t-bar with their
arms above their heads for the acquisition of planningCT scans. A whole body PET/CT scan was acquired 1-
10 weeks prior to the planning CT scan as part of the
routine diagnostic protocol for lung cancer. Patients
were positioned on a conventional diagnostic curved
couch without the t-bar, with a pillow for head support,
and arms typically down. No respiratory gating techniques
were used during the acquisition of the planning CT and
PET/CT scans as the tumor volumes were located in the
superior lobes of the lungs and the mediastinum, where
motion due to breathing is less pronounced than regions
near the diaphragm. Digital images of the PET/CT and
planning CT scans were made accessible via network
connections in DICOM format, and imported into a
treatment-planning database.
The PET/CT images were fused with the planning CT
scans within the treatment planning system (Eclipse,
Varian Medical Systems, Palo Alto CA). Rigid registra-
tion of the PET/CT and planning CT images was per-
formed using the Varian Rigid Registration package
(version 10.0). The PET image intensities were displayed
in units of Standardized Uptake Value (SUV) based on
the patient’s body weight, recorded during the PET/CT
acquisition and available in the DICOM data. Settings
for the PET image display were adjusted such that the
minimum SUV intensity was 2.0 Bq/ml.
Routine treatment planning was performed for all sub-
jects prior to this. Normal tissue and tumor volume con-
touring was done by radiation oncology and dosimetry
staff within the planning system and a treatment plan
was generated. The standard treatment prescription dose
for patients with head and neck cancers was 70 Gy in 35
fractions, delivered with intensity modulated radiotherapy,
and for patients with lung cancers was 40-60 Gy in
2.0-2.5 Gy fractions, delivered using a three-dimensional
conformal radiation therapy treatment plan.
For this study, automatic deformable registration (DIR)
of the PET/CT images with the planning CT scans was
performed on a GE Advantage Workstation 4.3 (GE Inte-
grated Registration, GE Medical Systems, Cleveland OH).
As the registration software is proprietary, there was lim-
ited control of its actions and the algorithms underpin-
nings. The performance of the registration was validated
using a cylindrical CT image quality phantom: known de-
formations were applied to the images of the phantom,
and the deformable registration software was then used in
an attempt to obtain the original image back [17]. The fi-
delity of image quality was then quantitatively analyzed.
This study showed that various deformations as large as
2-3 cm were recovered using the deformable registration
software.
The algorithm was observed to register the CT images
from the PET/CT scans with the planning CT scan in
two steps: a RIR followed by a DIR. During this process,
each PET voxel was mapped to a new position based on
Figure 1 Sagittal view of the fused PET and planning CT scans for a head and neck cancer subject. Results from the RIR (left) and DIR
(center), and fused view of the RIR and DIR PET (right) are shown. The difference in the position of the GTV for the primary tumor, indicated by a
white arrow, is measured to be 1.1 mm between RIR and DIR.
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resulting in a new PET/CT dataset that was deformably
registered with the planning CT. To improve the quality
of the registration and in some cases prevent the DIR al-
gorithm from failing, CT images from the combined
PET/CT scans outside the volume range of the planning
CT scans were manually removed from the series. The
resulting rigid and deformable PET image registration
against the planning CT scan is shown in Figure 1 in the
case of one head and neck cancer subject.
The registered images were then imported back into the
radiation treatment planning system. Five radiation oncolo-
gists were asked to manually contour 2 sets of GTVs on the
planning CT, one aided by the RIR PET image series and
the second aided by the DIR PET image series as shown inFigure 2 Coronal view of the planning CT with fused PET for a lung c
images are shown in red and blue, respectively. An intensity threshold equFigure 2. Diagnostic radiology reports were made available
to assist the radiation oncologists in their contouring, but
information regarding the type of registration used was
removed. The position and volume of the GTVs and ra-
diation doses delivered to each GTV using the original
treatment plan developed for each subject prior to the
study were compared using available tools within the
planning system. In the case of subjects with multiple
tumor foci, individual GTVs were contoured for the lar-
gest 2 cancer sites only.
The volumetric analysis of the difference between GTVs
obtained with RIR and DIR consisted in determining the
Dice similarity coefficient, DSC = 2 [VRIR ∩ VDIR]/[VRIR +
VDIR]. This metric has values ranging from 0 for no overlap
to 1 for perfect agreement between volumes.ancer subject. The GTV contours generated using the RIR and DIR PET
ivalent to SUV ≥ 2.0 was used for the PET image.
Table 1 Volumetric properties of the GTVs for the 10





Subject VRIR VDIR VOverlap DSC VRIR VDIR VOverlap DSC
(cm3) (cm3) (cm3) (cm3) (cm3) (cm3)
1 20.1 15.2 14.3 0.81 12.1 8.1 8.0 0.79
2 52.3 48.0 41.3 0.82 1.4 1.4 1.2 0.86
3 25.3 23.3 22.0 0.91 9.9 8.3 8.6 0.90
4 7.8 8.7 7.4 0.90 3.7 3.8 3.3 0.88
5 18.6 18.9 14.2 0.76 20.4 23.4 16.8 0.77
6 102.9 91.5 87.3 0.90 6.3 5.5 5.4 0.92
7 0.1 0.1 0.0 0.00 na na na na
8 4.4 5.6 3.9 0.78 na na na na
9 26.7 19.1 18.2 0.79 1.1 1.0 0.8 0.76
10 10.4 10.7 9.0 0.85 7.2 7.1 5.8 0.81
The volumes corresponding to the GTVs drawn using the rigid and
deformable image registration are labeled as VRIR and VDIR, respectively.
The acronym “na” means the GTV was not available.
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Head and neck cancer analysis
Ten head and neck cancer patients were selected for this
study. Primary sites varied greatly and ranged from the
larynx to the nasal cavity, and for eight out of ten pa-
tients, multiple nodes were observed. The properties of
the GTVs as contoured by radiation oncologists are
summarized in Table 1 and Figure 3. The volume of the
GTVs varied from 0.1 cm3 to 103 cm3. The average dis-
tance between the center of mass of the GTVs based on
the RIR and DIR was 1.8 mm with a standard deviation of
1.0 mm. The largest discrepancy observed was 4.5 mm in
subject 5 who had a primary tumor located in the leftFigure 3 Comparing the position of GTVs defined using RIR and DIR
of the displacement in the transverse plane for the head and neck (left) an
the histogram for a head and neck subject, where displacements of 4.5 mm
observed. Ten different symbols are used for the 10 different subjects. The
secondary nodes are drawn using smaller matching symbol in red.tonsil. The average Dice similarity coefficient was 0.84
(95% confidence interval: 0.73-0.94). This excludes a
subject who presented with a 0.1 cm3 primary node
confined to the epiglottis, resulting in the RIR and DIR
volumes not overlapping even though their spatial sep-
aration was measured to be only 1.6 mm. All GTVs re-
ceived at least 95% of the prescribed dose to ≥ 99% of
their volume. The difference in the mean dose to the
GTVs drawn from the RIR and DIR was less than 0.5%
in 17 out of 18 tumor sites, and was 2% for the second-
ary tumor of subject 5. The fraction of the volume of the
GTVs receiving 100% of the prescribed dose (V100%) is
presented in Table 2. The differences in V100% between
RIR and DIR were at most 5%.
Lung cancer analysis
Ten lung cancer patients were retained for this study.
The properties of the GTVs are presented in Table 3.
Five subjects had secondary tumor volumes in the medi-
astinum or hilar region that were identified using PET
images and contoured. The size of the GTVs varied from
about 3 cm3 to over 350 cm3. The spatial difference be-
tween the center of mass of the GTV from the RIR and
DIR was found to be consistently small for all patients,
on average 0.6 mm with a standard deviation of 0.6 mm.
These numbers increased to 0.7 mm when lymphatic
secondary nodes were excluded. For all 10 patients with
multiple nodes contoured, the exact same displacements
along the longitudinal axis were observed for the GTVs,
whereas displacements in the transverse plane varied
(Figure 3). The average Dice similarity coefficient was
0.93 (95% confidence interval: 0.80-1.00), and 0.90 when
excluding lymphatic nodes. All GTVs received at least
95% of the prescribed dose to ≥ 99% of their volumePET images. The displacement along the z-axis is shown as a function
d lung (right) cancer subjects. One point falls beyond the range of
in the transverse plane and 0.5 mm along the longitudinal axis are
primary tumors are indicated by larger symbols in blue, whereas
Table 2 Percentage of the volume of the GTVs receiving
at least 100% of the prescribed dose

























1 78 80 82 87 94 95 na na
2 64 69 93 93 98 99 na na
3 61 60 99 98 100 100 100 100
4 100 100 99 99 100 100 na na
5 83 78 98 96 100 100 91 91
6 69 72 100 100 97 97 100 100
7 100 100 na na 100 100 na na
8 99 100 na na 89 94 na na
9 100 100 76 76 100 100 83 84
10 100 100 100 100 67 67 31 31
The convention described in Table 1 is used.
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nificantly lower dose was delivered to the mediastinum
to spare the heart and lungs.
The difference in the average radiation dose received
by the GTVs drawn from the RIR and DIR was less than
1% for all subjects. The differences in V100% between
RIR and DIR were typically small and at most 5% as
shown in Table 2.
Discussion
Many studies investigating the performance and utility
of DIR have been conducted. Schwartz et al. [10] per-
formed DIR between planning CT and additional CT






Subject VRIR VDIR VOverlap DSC VRIR VDIR VOverlap DSC
(cm3) (cm3) (cm3) (cm3) (cm3) (cm3)
1 39.3 37.2 34.3 0.90 na na na na
2 71.4 77.2 65.5 0.88 na na na na
3 14.4 14.5 13.0 0.90 2.7 2.9 2.7 0.96
4 13.8 14.5 12.6 0.89 na na na na
5 11.4 11.0 10.5 0.94 6.8 6.8 6.8 1.00
6 38.0 36.2 28.1 0.76 27.0 27.0 27.0 1.00
7 26.4 26.4 24.0 0.91 na na na na
8 356.8 356.5 330.8 0.93 na na na na
9 61.1 59.8 55.4 0.92 12.6 12.6 12.6 1.00
10 63.3 62.7 60.9 0.97 21.0 21.0 21.0 1.00
The convention described in Table 1 is used.head and neck cancer patients for the purpose of evalu-
ating various adaptive radiotherapy techniques. They
demonstrated that an adaptive radiation therapy process
is feasible when using DIR and that improved sparing of
organs at risk could be achieved. Castadot et al. [11],
Fallone et al. [12] and Zhong et al. [13] performed a var-
iety of phantom measurements to evaluate a deformable
registration package and arrived at a protocol for sys-
tematic evaluation of DIR. Senthi et al. [14] quantified
differences in RIR and DIR for 10 re-irradiated lung can-
cer patients for whom initial planning CTs were regis-
tered with a subsequent planning CT used in a second
treatment plan. They observed improvements in regis-
tering organs at risk when using DIR as opposed to RIR;
however, they did not evaluate possible changes in pa-
tient dosimetry. Similarly, Ireland et al. [15] quantified
differences in RIR and DIR for five head and neck cancer
patients for whom PET/CT scans were registered against
planning CT images. They observed that DIR provided
a more accurate registration than RIR for a set of ana-
tomic landmarks, but did not evaluate differences in
patient dosimetry. Yin et al. [16] evaluated a variety of
DIR packages for the purpose of accurately registering
normal tissue function (SPECT) with the planning CT.
Despite these publications, no studies to date have eval-
uated possible differences in overall gross tumor vol-
ume (GTV) delineation, and possible changes in dose
to the GTV, when using RIR or DIR between PET/CT
and planning CT images.
Among all subjects with multiple tumors, there were
consistent longitudinal differences in the location of the
GTVs contoured with RIR and DIR. The internal RIR
within the DIR algorithm may be the cause for the con-
sistent difference in longitudinal location. This observa-
tion also suggests that DIR was performed on a slice-by-
slice basis, that is, no deformations were performed
longitudinally.
Although the size of the GTVs differed by as much as
30% between RIR and DIR, their locations were the same
to within 4.5 mm and the Dice similarity coefficients were
high for 32 out of 33 tumor volumes, indicating a high
level of compatibility. In the case of the subjects with lung
cancer, the location and size of the mediastinal and hilar
GTVs were observed to be identical for 4 out of 5 patients
because the radiation oncologists elected to treat a volume
not only limited to FDG-avid node(s), but also incorporat-
ing neighboring lymph nodes suspected to be involved. In
these cases, the GTVs were drawn based on patient anat-
omy using the planning and diagnostic CT scans.
Clinical target volumes were created around the RIR-
defined GTV using margins of 5-8 mm for head-and-
neck and 7 mm for lung cancer patients. Additionally,
4 mm margins were added to form the planning target
volumes (PTV). External beam planning was then
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ation dose delivered to the RIR and DIR drawn GTVs
were very similar as the DIR-defined GTVs were con-
tained within the RIR-defined PTV.
The sparing of healthy tissues and organs at risk was
not investigated given the small changes observed in the
position between RIR-defined and DIR-defined GTV.
Potential gains were assumed to be minimal.
Limitations
It is of note that when applying the DIR to the PET im-
ages the intensity of the voxels (Bq/ml) is not preserved.
This was observed to impact the maximum standardized
uptake value by less than 1%, and is assumed to be negli-
gible in the determination of GTVs when compared to
random systematic uncertainties during manual con-
touring which have been shown to be important [18].
Although the lung tumors were located in the upper
region of the lung where sensitivity to breathing motion
is reduced, gating techniques during the acquisition of
the planning CT and PET/CT would have further re-
duced the sensitivity to respiratory motion. The wide
time range between the acquisition of planning CT and
PET/CT scans of 1-15 days may have been a significant
factor in apparent tumor motion, particularly for patients
with rapidly developing tumors. Finally, the delineation of
hilar and mediastinal nodes by radiation oncologists for
lung cancer patients was often based on the anatomy ra-
ther than metabolic data, which may have biased the re-
sults. As such, the data for the lung cancer patients were
presented with and without these secondary nodes.
Conclusion
Deformable image registration has become an important
component of image-guided and adaptive radiation ther-
apy protocols. Commercial software to perform DIR is
now available at the BC Cancer Agency for registering
PET/CT images to planning CT scans, but this study re-
vealed minimal benefits. Unless there are significant ana-
tomical differences between the PET/CT and planning
CT, the value of deformable registration between PET/
CT and planning CT images was shown to be marginal
value when delineating gross tumor volumes.
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